Coronavirus Disease (COVID-19) Information

In continued consultation with the Medical Director of The William Breman Jewish Home, Dr. Elliott Jackson, Jewish HomeLife follows the guidelines from the Centers for Disease Control (CDC) and Center for Medicare and Medicaid Services (CMS). Safety is our primary concern for our residents, clients and staff. We have made significant efforts to make sure all of our team members and residents are vaccinated. Through our aggressive PPE procurement efforts, widespread contact tracing and access to highly sensitive and accurate testing we have processes in place to contain the virus if (when) faced with cases. We have led the way in infection control, and have earned our families’ trust.

We are open for business and excited to welcome back our families. Check here for our visitation and admissions guidelines.

Berman Commons visitation

The Cohen Home visitation

Protecting our Residents and Staff

Among our senior care peers, Jewish HomeLife is leading the way with regard to testing, contact tracing, PPE, infection control and making efforts to vaccinate our residents and staff. We have a proven track record of isolating and containing any instances of COVID-19, and keeping our communities safe and healthy for residents and team members.

Watch our 2-minute video to see how the exceptional men and women of Jewish HomeLife have come together to protect our residents and each other.

From activities and dining to visitation and care, our team members compassionately balance safety requirements with the need to reduce isolation and keep our residents engaged and active.

We have comprehensive admissions and readmissions guidelines that follow CMS and CDC recommendations for our residents to ensure their health and safety, as well as our staff and their families.



Jewish HomeLife Safety Pillars

Since the first days of the pandemic, Jewish HomeLife continually earns the trust of our residents, clients, and families by operating all our residential communities and at-home care services with four guiding safety pillars, to the best of our ability, each day.

  • Ensure the safety of our residents and clients
  • Ensure the safety of our staff
  • Continue to educate and train our team members about infection control and COVID-19, based upon evolving virus developments
  • Continue our partnerships with all local, state, and federal agencies

View our most recent infection control inspections

Over the course of this year and throughout the pandemic, we have had seven surveys from the State of Georgia as well as Fulton county. Each one has shown we are deficiency-free.

William Breman Jewish Home (10/21/2020)
William Breman Jewish Home (06/16/2020)

Care for a New Age

Jewish HomeLife was put to the test early in the pandemic, having one of the first assisted living communities in Georgia with confirmed cases. Through our aggressive PPE procurement efforts, widespread contact tracing, access to highly sensitive and accurate PCR testing with 24-hour results, and excellent staff training, we very quickly contained the virus and had minimal spread. We have led the way in infection control, and have earned our families’ trust.

Watch our Chief Operating Officer Jeff Gopen, who leads our COVID-19 Incident Command Center, answers frequently asked questions about what our communities are doing every day to keep our residents and staff safe.


Vaccine Q&A with Dr. David Rimland

In our efforts to help our staff feel more comfortable with the upcoming COVID vaccine, Jewish HomeLife President & CEO Harley asked Infectious Disease specialist Dr. David Rimland, to help. JHL staff submitted questions and concerns, and we recorded a Zoom call with Dr. Rimland  to answer them. The result is an excellent 38-minute video with Dr. Rimland answering these questions in a very easy-to-understand style.

Dr. Rimland served as Chief of Infectious Diseases at the Atlanta VA Medical Center from 1990 until his retirement in 2015. Prior to his retirement after 38 years of service to Emory University, Dr. Rimland had been a principal investigator and investigator for numerous clinical trials on HIV.